• Adacel polio

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	Not less than 2 IU (2 Lf)
  tetanus toxoid	Not less than 20 IU (5 Lf)
  pertussis toxoid	2.5 mcg
  fibrillar hemagglutinin	5 mcg
  pertactin	3 mcg
  Fimbriae (type 2 and 3)	5 mcg
  Inactivated poliovirus type 1	29 units of D3 antigen
  Inactivated poliovirus type 2	7 units of D3 antigen
  Inactivated poliovirus type 3	26 units of D3 antigen

  ATC: J07CA02

  Manufacturer: Sanofi-Aventis Zrt.

• Boostrix polio

  Form: solution for injection in ampoule-syringe

  Active substance	Dosage
  diphtheria toxoid	> or equal to 2 IU (2.5 Lf)
  aluminum phosphate	0.2 mg Al 3+
  inactivated poliovirus type 1	40 units of antigen D
  inactivated poliovirus type 2	8 units of antigen D
  inactivated poliovirus type 3	32 units of antigen D
  tetanus toxoid	> or equal 20 IU (5 Lf)
  aluminum hydroxide hydrate	0.3 mg Al 3+
  Bordetella pertussis antigens	8 mcg + 8 mcg + 2.5 mcg

  ATC: J07CA02

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Infanrix ipv

  Form: suspension for injection

  Active substance	Dosage
  inactivated poliovirus type 1	40 units of antigen D
  inactivated poliovirus type 2	8 units of antigen D
  inactivated poliovirus type 3	32 units of antigen D
  Diphtheria toxoid	or equal to 30 IU
  Tetanus toxoid	or equal to 40 IU
  pertussis antigens	25 mcg + 25 mcg + 8 mcg

  ATC: J07CA02

  Manufacturer: GlaxoSmithKline Biologicals S.A.

• Pentaxim

  Form: powder and suspension for preparation of injection suspension

  Active substance	Dosage
  Inactivated poliovirus type 1	40 units of antigen D
  Inactivated poliovirus type 2	8 units of antigen D
  Inactivated poliovirus type 3	32 units of antigen D
  Haemophilus influenzae type b conjugated polysaccharide-tetanus toxoid conjugate	10 mcg
  Diphtheria toxoid	not less than 30 IU
  Tetanus toxoid	not less than 40 IU
  Bordetella pertussis antigens	25 mcg + 25 mcg

  ATC: J07CA02

  Manufacturer: Sanofi Winthrop Industrie